Witherington; Jason
Patent Applications and Registrations
Patent applications and USPTO patent grants for Witherington; Jason.The latest application filed is for "covalent conjugates".
Company Profile
1.16.28
- Witherington; Jason - Stevenage GB
- Witherington; Jason - Harlow GB
- Witherington; Jason - Essex GB
- Witherington; Jason - Hertfordshire GB
- Witherington; Jason -
- Witherington; Jason - Sawbridgeworth GB
Patent Activity
| Patent | Date |
|---|---|
| Covalent Conjugates App 20190142949 - BROWN; John Alexander ; et al. | 2019-05-16 |
| Covalent Conjugates Of Bet Inhibitors And Alpha Amino Acid Esters App 20180117165 - BROWN; John Alexander ; et al. | 2018-05-03 |
| Novel Compounds App 20170145021 - BAILEY; James ; et al. | 2017-05-25 |
| Benzodiazepine bromodomain inhibitor Grant 9,598,420 - Bailey , et al. March 21, 2 | 2017-03-21 |
| Benzodiazepine Bromodomain Inhibitor App 20150299210 - BAILEY; James ; et al. | 2015-10-22 |
| Benzodiazepine bromodomain inhibitor Grant 9,102,677 - Bailey , et al. August 11, 2 | 2015-08-11 |
| Benzodiazepine Bromodomain Inhibitor App 20120252781 - Bailey; James ; et al. | 2012-10-04 |
| Oxadiazole derivatives active on sphingosine-1-phosphate (S1P) Grant 8,222,245 - Demont , et al. July 17, 2 | 2012-07-17 |
| Benzazepine derivatives for the treatment of neurological disorders Grant 8,207,331 - Bamford , et al. June 26, 2 | 2012-06-26 |
| S1p1 Agonists Comprising A Bicyclic N-containing Ring App 20120101083 - Bailey; James Matthew ; et al. | 2012-04-26 |
| Thiadiazole Derivatives And Their Use For The Treatment Of Disorders Mediated By S1p1 Receptors App 20120101086 - Bailey; James Matthew ; et al. | 2012-04-26 |
| Imidazopyridine Derivatives As Acid Pump Antagonists App 20100311740 - Bamford; Mark James ; et al. | 2010-12-09 |
| Oxadiazole Derivatives Active On Sphingosine-1-phosphate (sip) App 20100273771 - Demont; Emmanuel Hubert ; et al. | 2010-10-28 |
| Benzazepine derivatives for the treatment of neurological disorders Grant 7,799,773 - Bamford , et al. September 21, 2 | 2010-09-21 |
| Aryl And Heteroaryl Sulphonamides As Growth Hormone Secretagogue Receptor Agonists App 20100179168 - Blaney; Emma Louise ; et al. | 2010-07-15 |
| Benzazepine Derivatives For The Treatment of Neurological Disorders App 20100145040 - Bamford; Mark James ; et al. | 2010-06-10 |
| Compounds Grant 7,713,978 - King , et al. May 11, 2 | 2010-05-11 |
| Benzazepine derivatives for the treatment of neurological disorders Grant 7,704,994 - Sehmi , et al. April 27, 2 | 2010-04-27 |
| Benzazepine derivatives for the treatment of neurological disorders Grant 7,696,193 - Sehmi , et al. April 13, 2 | 2010-04-13 |
| Benzazepine Derivatives For The Treatment Of Neurological Disorders App 20090105226 - BAMFORD; Mark James ; et al. | 2009-04-23 |
| Derivatives of Imidazo [1,2-A] Pyridine Useful as Medicaments For Treating Gastrointestinal Diseases App 20080255358 - Bamford; Mark James ; et al. | 2008-10-16 |
| Alpha-4 Integrin Mediated Cell Adhesion Inhibitors for the Treatment or Prevention of Inflammatory Diseases App 20080234301 - Ward; Robert William ; et al. | 2008-09-25 |
| Compounds Grant 7,410,984 - Witherington , et al. August 12, 2 | 2008-08-12 |
| Piperazine derivatives useful for the treatment of gastrointestinal disorders Grant 7,381,728 - Dean , et al. June 3, 2 | 2008-06-03 |
| Imidazopyridine derivatives as kinase inhibitors Grant 7,348,339 - Bailey , et al. March 25, 2 | 2008-03-25 |
| Benzazepine Derivatives For The Treatment Of Neurological Disorders App 20070299056 - Bamford; Mark James ; et al. | 2007-12-27 |
| Pyrazolopyridines and pyrazolopyridazines as antidiabetics Grant 7,297,792 - Garland , et al. November 20, 2 | 2007-11-20 |
| Piperazine Derivatives Useful for the Treatment of Gastrointestinal Disorders App 20070259877 - Dean; David Kenneth ; et al. | 2007-11-08 |
| Novel Compounds App 20070238737 - King; Nigel Paul ; et al. | 2007-10-11 |
| Benzazepine derivatives for the treatment of neurological and psychiatric disorders App 20070185089 - Bamford; Mark James ; et al. | 2007-08-09 |
| Benzazepine derivatives as histamine h3 antagonists App 20070060566 - Bailey; Nicholas ; et al. | 2007-03-15 |
| Pyrazolopyridines And Pyrazolopyridazines Adn Antidiabetics App 20060223800 - Garland; Stephen ; et al. | 2006-10-05 |
| Pyrazolopyridines and pyrazolopyridazines as antidiabetics Grant 7,109,199 - Garland , et al. September 19, 2 | 2006-09-19 |
| Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors Grant 7,105,532 - Rawlings , et al. September 12, 2 | 2006-09-12 |
| Benzo d!azepine derivatives for the treatment of neurological disorders App 20060040918 - Bamford; Mark James ; et al. | 2006-02-23 |
| Novel compounds App 20050288337 - Witherington, Jason ; et al. | 2005-12-29 |
| Imidazopyridine derivatives as kinase inhibitors App 20050197328 - Bailey, Nicholas ; et al. | 2005-09-08 |
| Medicaments App 20050153978 - Alberti, Michael John ; et al. | 2005-07-14 |
| Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors App 20040077681 - Rawlings, Derek Anthony ; et al. | 2004-04-22 |
| Pyrazolopyridines and pyrazolopyridazines as antidabetics App 20040019052 - Garland, Stephen ; et al. | 2004-01-29 |
| Protease inhibitors Grant 6,566,373 - Gribble , et al. May 20, 2 | 2003-05-20 |
| Protease inhibitors App 20020082426 - Fenwick, Ashley E. ; et al. | 2002-06-27 |
| Protease inhibitors App 20020013360 - Gribble, Andrew D. ; et al. | 2002-01-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 